Bringing real-time cancer diagnostics directly to the operating room, Refined Laser Systems | Refined Diagnostics has closed a $2.9M seed round.
The Münster, Germany-based medical technology company is developing high-precision laser microscopy to enable molecular tissue analysis within minutes. This technology aims to empower surgeons and pathologists to identify cancer cells during surgery, a significant shift from current methods that often delay critical diagnostic decisions for hours or days. The capital will support their mission to reduce repeat procedures, patient stress, and treatment costs.
.png&w=3840&q=75)
